Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease

PROVIDER: PRJNA818675 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18432443.fastq.gz	Fastqsanger.gz
	SRR18432444.fastq.gz	Fastqsanger.gz
	SRR18432445.fastq.gz	Fastqsanger.gz
	SRR18432446.fastq.gz	Fastqsanger.gz
	SRR18432447.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Project description:Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease

| PRJNA1013074 | ENA

Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease

Project description:Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease

| PRJNA819078 | ENA

Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease

Project description:Metastatic gastric carcinoma is a highly lethal cancer that responds poorly to conventional and molecularly targeted therapies. Despite its clinical relevance, the mechanisms underlying the behavior and therapeutic response of this disease are poorly understood owing, in part, to a paucity of tractable models that faithfully recapitulate different subtypes of the human disease. To close this gap, we developed methods to somatically introduce different oncogenic lesions directly into the stomach epithelium and show that genotypic configurations observed in patients produce metastatic gastric cancers that recapitulate the histological, molecular, and clinical features of all non-viral molecular subtypes of the human disease. Applying this platform to both wild-type and immune-deficient mice revealed previously unappreciated links between the genotype, organotropism and immune surveillance of metastatic cells that produced distinct patterns of metastasis that were mirrored in patients. Our results establish and credential a highly portable platform for producing autochthonous cancer models with flexible genotypes and host backgrounds, which can unravel mechanisms of gastric tumorigenesis or test new therapeutic concepts aimed at improving outcomes in gastric cancer patients.

2023-09-03 | GSE199261 | GEO

A Tumour-Resident Lgr5+ Stem Cell - Like Pool Drives the Establishment and Progression of Advanced Gastric Cancers

Project description:Gastric cancer is amongst the most prevalent and deadliest cancers globally. To derive mechanistic insight into the pathways governing this disease, we generated a stomach-specific Claudin18-IRES-CreERT2 mouse line to model advanced human gastric cancer and investigated the role of tumour resident Lgr5+ stem-like cells in gastric cancer. Mouse lines incorporating Cldn18-driven conditional dysregulation of the Wnt, RTK and Trp53 pathways modelled metastatic Chromosomal Instable-type gastric cancer. In parallel, we supplemented these cancer models with orthotopic transplantation of cancer organoids to derive detailed mechanistic insight into the roles of Lgr5+ cancer stem cell in gastric cancer. Here we show, we recapitulated advanced human gastric cancer in terms of disease phenotype, aberrant gene expression profile, molecular markers, and sites of distant metastases. Importantly, we established that tumour-resident Lgr5+ stem-like cells are critical to the initiation and maintenance of tumour burden, and are obligatory for the establishment of metastases. These models will be invaluable for deriving clinically-relevant mechanistic insights into cancer progression and as pre-clinical models for evaluating novel therapeutics.

2021-11-26 | GSE184613 | GEO

Somatic tissue engineering in mouse models reveals an actionable role for WNT pathway alterations in prostate cancer metastasis

Project description:To study genetic factors that influence the progression and therapeutic response of advanced prostate cancer, we developed a fast and flexible system that introduces genetic alterations relevant to human disease directly into the prostate glands of mice using tissue electroporation. These electroporation based genetically engineered mouse models (EPO-GEMM) recapitulate features of traditional germline models and, by modeling genetic factors linked to late stage human disease, can produce tumors that are metastatic and castration resistant. Unexpectedly, a subset of particularly metastatic tumors acquired WNT pathway alterations, which are also associated with metastatic prostate cancer in humans. Harnessing features linked to the EPO-GEMM approach, we validate the WNT pathway as a key event in driving metastatic disease, a finding that we confirm in an orthogonal approach using mouse prostate organoids. Moreover, we show that tumors harboring WNT pathway alterations are sensitive to pharmacological WNT pathway inhibition. Thus, by leveraging the power of EPO-GEMMs, our studies reveal a functional role for WNT signaling in driving prostate cancer metastasis and validate the WNT pathway as an actionable therapeutic target in metastatic prostate cancer.

2020-04-28 | GSE139340 | GEO

mouse gut metagenome

Project description:Virome features in two mouse models of inflammatory bowel disease

| PRJNA938068 | ENA

Mouse models of neutropenia reveal progenitor-stage-specific defects [Fluidigm]

Project description:Mouse models of neutropenia reveal progenitor-stage-specific defects [Fluidigm]

| PRJNA596758 | ENA

Transcriptional heterogeneity in primary and metastatic gastric cancer revealed using single-cell RNA sequencing

Project description:Deciphering intra- and inter-tumoral heterogeneity is essential for understanding gastric cancer (GC) biology and identifying effective therapeutic targets. We used single-cell RNA sequencing (scRNA-seq) to reveal the transcriptional heterogeneity of diverse cells within primary and metastatic GC and their roles in disease progression.

2022-02-22 | GSE163558 | GEO

Mouse models of neutropenia reveal progenitor-stage-specific defects [scATAC-Seq]

Project description:Mouse models of neutropenia reveal progenitor-stage-specific defects [scATAC-Seq]

| PRJNA596750 | ENA

Mouse models of neutropenia reveal progenitor-stage-specific defects [ChIP-Seq]

Project description:Mouse models of neutropenia reveal progenitor-stage-specific defects [ChIP-Seq]

| PRJNA596666 | ENA